An overview of preparation and evaluation sustained-release injectable microspheres

References

• Akhtar S, Lewis KJ. Antisense oligonucleotide delivery to cultured macrophages is improved by incorporation into sustained-release biodegradable polymer microspheres. Int J Pharm 1997; 151: 57–67
   Web of Science ®Google Scholar
• Ali SAM, Doherty PJ, Williams DF. Molecular biointeractions of biomedical polymers with extracellular exudate and inflammatory cells and their effects on the biocompatibility, in vivo. Biomaterials 1994; 15: 779–85
   PubMed Web of Science ®Google Scholar
• Allison SD. Analysis of initial burst in PLGA microparticles. Expert Opin Drug Deliv 2008; 5: 615–28
   PubMed Web of Science ®Google Scholar
• Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 1997; 28: 5–24
   PubMed Web of Science ®Google Scholar
• Andrianov AK, Chen J, Payne LG. Preparation of hydrogel microspheres by coacervation of aqueous polyphosphazene solutions. Biomaterials 1998; 19: 109–15
   PubMed Web of Science ®Google Scholar
• Bahrami M, Ranjbarian S. Production of micro-and nano-composite particles by supercritical carbon dioxide. J Supercrit Fluids 2007; 40: 263–83
   Web of Science ®Google Scholar
• Björses K, Faxälv L, Montan C, Wildt-Persson K, Fyhr P, Holst J, Lindahl TL. In vitro and in vivo evaluation of chemically modified degradable starch microspheres for topical haemostasis. Acta Biomater 2010; 7: 2558–65
   Google Scholar
• Brannon-Peppas L. Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery. Int J Pharm 1995; 116: 1–9
   Web of Science ®Google Scholar
• Buchwald P. Direct, differential equation based in vitro in vivo correlation (IVIVC) method. J Pharm Pharmacol 2003; 55: 495–504
   PubMed Web of Science ®Google Scholar
• Checa-Casalengua P, Jiang C, Bravo-Osuna I, Tucker BA, Molina-Martinez IT, Young MJ, Herrero-Vanrell R. Preservation of biological activity of glial cell line-derived neurotrophic factor (GDNF) after microencapsulation and sterilization by gamma irradiation. Int J Pharm 2012; 436: 274–81
   Google Scholar
• Cheng J, Teply BA, Sherifi I, Sung J, Luther G, Gu FX, Levy-Nissenbaum E, Radovic-Moreno AF, Langer R, Farokhzad OC. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials 2007; 28: 869–76
   PubMed Web of Science ®Google Scholar
• Choi SH, Park TG. Hydrophobic ion pair formation between leuprolide and sodium oleate for sustained release from biodegradable polymeric microspheres. Int J Pharm 2000; 203: 193–202
   PubMed Web of Science ®Google Scholar
• Choi SH, Park TG. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method. Int J Pharm 2006; 311: 223–8
   PubMed Web of Science ®Google Scholar
• Chu DF, Fu XQ, Liu WH, Liu K, Li YX. Pharmacokinetics and in vitro and in vivo correlation of huperzine A loaded poly(lactic-co-glycolic acid) microspheres in dogs. Int J Pharm 2006; 325: 116–23
   PubMed Web of Science ®Google Scholar
• Cianni R, Urigo C, Notarianni E, Saltarelli A, D'Agostini A, Iozzino M, Dornbusch T, Cortesi E. Radioembolisation using yttrium 90 (Y-90) in patients affected by unresectable hepatic metastases. Radiol Medica 2010; 115: 619–33
   PubMedGoogle Scholar
• Costantino HR, Johnson OL, Zale SE. Relationship between encapsulated drug particle size and initial release of recombinant human growth hormone from biodegradable microspheres. J Pharm Sci 2004; 93: 2624–34
   PubMed Web of Science ®Google Scholar
• Deng Y, Qi D, Deng C, Zhang X, Zhao D. Superparamagnetic high-magnetization microspheres with an Fe3O4@ SiO2 core and perpendicularly aligned mesoporous SiO2 shell for removal of microcystins. J Am Chem Soc 2008; 130: 28–9
   PubMed Web of Science ®Google Scholar
• Du Z, Guan YX, Yao SJ, Zhu ZQ. Supercritical fluid assisted atomization introduced by an enhanced mixer for micronization of lysozyme: Particle morphology, size and protein stability. Int J Pharm 2011; 421: 258–68
   PubMedGoogle Scholar
• Ertl B, Platzer P, Wirth M, Gabor F. Poly(D, L-lactic-co-glycolic acid) microspheres for sustained delivery and stabilization of camptothecin. J Control Release 1999; 61: 305–17
   PubMed Web of Science ®Google Scholar
• Fernandez-Carballido A, Herrero-Vanrell R, Molina-Martinez IT, Pastoriza P. Sterilized ibuprofen-loaded poly(D, L-lactide-co-glycolide) microspheres for intra-articular administration: Effect of gamma-irradiation and storage. J Microencapsul 2004; 21: 653–65
   PubMed Web of Science ®Google Scholar
• Fini A, Cavallari C, Ospitali F, Gonzalez-Rodriguez ML. Theophylline-loaded compritol microspheres prepared by ultrasound-assisted atomization. J Pharm Sci 2011; 100: 743–57
   PubMed Web of Science ®Google Scholar
• Freitas S, Merkle HP, Gander B. Microencapsulation by solvent extraction/evaporation: Reviewing the state of the art of microsphere preparation process technology. J Control Release 2005; 102: 313–32
   PubMed Web of Science ®Google Scholar
• Fu K, Pack DW, Klibanov AM, Langer R. Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid)(PLGA) microspheres. Pharm Res 2000; 17: 100–6
   PubMed Web of Science ®Google Scholar
• Gavini E, Chetoni P, Cossu M, Alvarez MG, Saettone MF, Giunchedi P. PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: In vitro/in vivo studies. Eur J Pharm Biopharm 2004; 57: 207–12
   PubMed Web of Science ®Google Scholar
• Gefvert O, Eriksson B, Persson P, Helldin L, Bjorner A, Mannaert E, Remmerie B, Eerdekens M, Nyberg S. Pharmacokinetics and D2 receptor occupancy of long-acting injectable risperidone (Risperdal Consta TM) in patients with schizophrenia. Int J Neuropsychopharmacol 2005; 8: 27–36
   PubMed Web of Science ®Google Scholar
• Genta I, Perugini P, Pavanetto F, Maculotti K, Modena T, Casado B, Lupi A, Iadarola P, Conti B. Enzyme loaded biodegradable microspheres in vitro: Ex vivo evaluation. J Control Release 2001; 77: 287–95
   PubMed Web of Science ®Google Scholar
• Giunchedi P, Conti B, Genta I, Conte U, Puglisi G. Emulsion spray-drying for the preparation of albumin-loaded PLGA microspheres. Drug Dev Ind Pharm 2001; 27: 745–50
   PubMed Web of Science ®Google Scholar
• Gowda DV, Ravi V, Shivakumar HG, Hatna S. Preparation, evaluation and bioavailability studies of indomethacin-bees wax microspheres. J Mater Sci 2009; 20: 1447–56
   Google Scholar
• Grellier M, Granja PL, Fricain JC, Bidarra SJ, Renard M, Bareille R, Bourget C, Amédée J, Barbosa MA. The effect of the co-immobilization of human osteoprogenitors and endothelial cells within alginate microspheres on mineralization in a bone defect. Biomaterials 2009; 30: 3271–8
   PubMed Web of Science ®Google Scholar
• Gupta RK, Alroy J, Alonso MJ, Langer R, Siber GR. Chronic local tissue reactions, long term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers. Vaccine 1997; 15: 1716–23
   PubMed Web of Science ®Google Scholar
• Habraken W, Boerman OC, Wolke JGC, Mikos AG, Jansen JA. In vitro growth factor release from injectable calcium phosphate cements containing gelatin microspheres. J Biomed Mater Res A 2009; 91: 614–22
   PubMed Web of Science ®Google Scholar
• Habraken W, Wolke JGC, Mikos AG, Jansen JA. Injectable PLGA microsphere/calcium phosphate cements: Physical properties and degradation characteristics. J Biomater Sci Polym Ed 2006; 17: 1057–74
   PubMed Web of Science ®Google Scholar
• Han B, Wang HT, Liu HY, Hong H, Lv W, Shang ZH. Preparation of pingyangmycin PLGA microspheres and related in vitro/in vivo studies. Int J Pharm 2010; 398: 130–6
   PubMed Web of Science ®Google Scholar
• He W, Jiang Z, Suo Q, Li G. Mechanism of dispersing an active component into a polymeric carrier by the SEDS-PA process. J Mater Sci 2010; 45: 467–74
   Web of Science ®Google Scholar
• Hermeling S, Crommelin DJA, Schellekens H, Jiskoot W. Structure-immunogenicity relationships of therapeutic proteins. Pharm Res 2004; 21: 897–903
   PubMed Web of Science ®Google Scholar
• Holger P, Jean-Claude B, Helmut S, Marie-Laure D. Pharmacokinetic and technical comparison of Sandostatin® LAR® and other formulations of long-acting octreotide. BMC Res Notes 2011; 4: 344–51
   PubMedGoogle Scholar
• Hutchinson FG, 1982. Continuous release pharmaceutical compositions. EP Patent 0,058,481
   Google Scholar
• Jain RA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide)(PLGA) devices. Biomaterials 2000; 21: 2475–90
   PubMed Web of Science ®Google Scholar
• Jain S, Malyala P, Pallaoro M, Giuliani M, Petersen H, O'Hagan DT, Singh M. A two-stage strategy for sterilization of poly(lactide-co-glycolide) particles by gamma-irradiation does not impair their potency for vaccine delivery. J Control Release 2011; 100: 646–54
   Google Scholar
• Jalil R, Nixon JR. Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: Problems associated with preparative techniques and release properties. J Microencapsulation 1990; 7: 297–325
   PubMed Web of Science ®Google Scholar
• Jameela SR, Kumary TV, Lal AV, Jayakrishnan A. Progesterone-loaded chitosan microspheres: A long acting biodegradable controlled delivery system. J Control Release 1998; 52: 17–24
   PubMed Web of Science ®Google Scholar
• Jeong B, Bae YH, Kim SW. In situ gelation of PEG-PLGA-PEG triblock copolymer aqueous solutions and degradation thereof. J Biomed Mater Res 2000; 50: 171–7
   PubMed Web of Science ®Google Scholar
• Jiang W, Gupta RK, Deshpande MC, Schwendeman SP. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. Adv Drug Deliv Rev 2005; 57: 391–410
   PubMed Web of Science ®Google Scholar
• Jordan F, Naylor A, Kelly CA, Howdle SM, Lewis A, Illum L. Sustained release hGH microsphere formulation produced by a novel supercritical fluid technology: In vivo studies. J Control Release 2010; 141: 153–60
   PubMed Web of Science ®Google Scholar
• Kang E, Robinson J, Park K, Cheng JX. Paclitaxel distribution in poly(ethylene glycol)/poly(lactide-co-glycolic acid) blends and its release visualized by coherent anti-Stokes Raman scattering microscopy. J Control Release 2007; 122: 261–8
   PubMed Web of Science ®Google Scholar
• Kawashita M, Domi S, Saito Y, Aoki M, Ebisawa Y, Kokubo T, Saito T, Takano M, Araki N, Hiraoka M. In vitro heat generation by ferrimagnetic maghemite microspheres for hyperthermic treatment of cancer under an alternating magnetic field. J Mater Sci Mater Med 2008; 19: 1897–903
   PubMed Web of Science ®Google Scholar
• Kawashita M, Miyaji F, Kokubo T, Takaoka GH, Yamada I, Suzuki Y, Kajiyama K. Phosphorus-implanted glass for radiotherapy: Effect of implantation energy. J Am Ceram Soc 1999; 82: 683–8
   Google Scholar
• Kawashita M, Shineha R, Kim HM, Kokubo T, Inoue Y, Araki N, Nagata Y, Hiraoka M, Sawada Y. Preparation of ceramic microspheres for in situ radiotherapy of deep-seated cancer. Biomaterials 2003; 24: 2955–63
   PubMedGoogle Scholar
• Kissel T, Li YX, Volland C, G-Srich S, Koneberg R. Parenteral protein delivery systems using biodegradable polyesters of ABA block structure, containing hydrophobic poly(lactide-co-glycolide) A blocks and hydrophilic poly(ethylene oxide) B blocks. J Control Release 1996; 39: 315–26
   Web of Science ®Google Scholar
• Kostanski JW, DeLuca PP. A novel in vitro release technique for peptide-containing biodegradable microspheres. AAPS PharmSciTech 2000; 1: 30–40
   Google Scholar
• Li Y, Xu X, Qi D, Deng C, Yang P, Zhang X. Novel Fe3O4-TiO2 core-shell microspheres for selective enrichment of phosphopeptides in phosphoproteome analysis. J Proteome Res 2008; 7: 2526–38
   PubMed Web of Science ®Google Scholar
• Lim ST, Martin GP, Berry DJ, Brown MB. Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan. J Control Release 2000; 66: 281–92
   PubMed Web of Science ®Google Scholar
• Loo JCK, Riegelman S. New method for calculating the intrinsic absorption rate of drugs. J Pharm Sci 1968; 57: 918–28
   PubMed Web of Science ®Google Scholar
• Loscertales IG, Barrero A, Guerrero I, Cortijo R, Marquez M, Ganan-Calvo AM. Micro/nano encapsulation via electrified coaxial liquid jets. Science 2002; 295: 1695–98
   PubMed Web of Science ®Google Scholar
• Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers 2011; 3: 1377–97
   PubMed Web of Science ®Google Scholar
• Mao S, Xu J, Cai C, Germershaus O, Schaper A, Kissel T. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres. Int J Pharm 2007; 334: 137–48
   PubMed Web of Science ®Google Scholar
• Martinez-Sancho C, Herrero-Vanrell R, Negro S. Study of gamma-irradiation effects on aciclovir poly(D, L-lactic-co-glycolic) acid microspheres for intravitreal administration. J Control Release 2004; 99: 41–52
   PubMed Web of Science ®Google Scholar
• Men Y, Tamber H, Audran R, Gander B, Corradin G. Induction of a cytotoxic T lymphocyte response by immunization with a malaria specific CTL peptide entrapped in biodegradable polymer microspheres. Vaccine 1997; 15: 1405–12
   PubMed Web of Science ®Google Scholar
• Mitra A, Wu Y. Use of in vitro-in vivo correlation (IVIVC) to facilitate the development of polymer-based controlled release injectable formulations. Recent Pat Drug Deliv Formul 2010; 4: 94–104
   PubMedGoogle Scholar
• Mohaghegh M, Tafaghodi M. Dextran microspheres could enhance immune responses against PLGA nanospheres encapsulated with tetanus toxoid and Quillaja saponins after nasal immunization in rabbit. Pharm Dev Technol 2011; 16: 36–43
   PubMed Web of Science ®Google Scholar
• Mohanan D, Gander B, Kundig TM, Johansen P. Encapsulation of antigen in poly(d, l-lactide-co-glycolide) microspheres protects from harmful effects of γ-irradiation in mice. Eur J Pharm Biopharm 2012; 80: 274–81
   PubMed Web of Science ®Google Scholar
• Montanari L, Costantini M, Signoretti EC, Valvo L, Santucci M, Bartolomei M, Fattibene P, Onori S, Faucitano A, Conti B. Gamma irradiation effects on poly(D, L-lactictide-co-glycolide) microspheres. J Control Release 1998; 56: 219–29
   PubMed Web of Science ®Google Scholar
• Motulsky A, Lafleur M, Couffin-Hoarau AC, Hoarau D, Boury F, Benoit JP, Leroux JC. Characterization and biocompatibility of organogels based on L-alanine for parenteral drug delivery implants. Biomaterials 2005; 26: 6242–53
   PubMed Web of Science ®Google Scholar
• Mu L, Feng SS. Fabrication, characterization and in vitro release of paclitaxel (Taxol®) loaded poly(lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers. J Control Release 2001; 76: 239–54
   PubMed Web of Science ®Google Scholar
• Murty SB, Wei Q, Thanoo BC, DeLuca PP. In vivo release kinetics of octreotide acetate from experimental polymeric microsphere formulations using oil/water and oil/oil processes. AAPS PharmSciTech 2004; 5: 90–9
   Google Scholar
• Nagai N, Kumasaka N, Kawashima T, Kaji H, Nishizawa M, Abe T. Preparation and characterization of collagen microspheres for sustained release of VEGF. J Mater Sci Mater Med 2010; 21: 1891–8
   PubMedGoogle Scholar
• O'Hara T, Hayes S, Davis J, Devane J, Smart T, Dunne A. In vivo-in vitro correlation (IVIVC) modeling incorporating a convolution step. J Pharmacokinet Pharmacodyn 2001; 28: 277–98
   PubMed Web of Science ®Google Scholar
• Partidos CD, Vohra P, Jones D, Farrar G, Steward MW. CTL responses induced by a single immunization with peptide encapsulated in biodegradable microparticles. J Immunol Methods 1997; 206: 143–51
   PubMed Web of Science ®Google Scholar
• Porta GD, Adami R, Del Gaudio P, Prota L, Aquino R, Reverchon E. Albumin/gentamicin microspheres produced by supercritical assisted atomization: Optimization of size, drug loading and release. J Pharm Sci 2010; 99: 4720–9
   PubMedGoogle Scholar
• Qi D, Zhang H, Tang J, Deng C, Zhang X. Facile synthesis of mercaptophenylboronic acid-functionalized core-shell structure Fe3O4@ C@ Au magnetic microspheres for selective enrichment of glycopeptides and glycoproteins. J Phys Chem C 2010; 114: 9221–6
   Web of Science ®Google Scholar
• Rawat A, Stippler E, Shah VP, Burgess DJ. Validation of USP apparatus 4 method for microsphere in vitro release testing using Risperdal® Consta®. Int J Pharm 2011; 420: 198–205
   PubMed Web of Science ®Google Scholar
• Reverchon E. Supercritical antisolvent precipitation of micro-and nano-particles. J Supercrit Fluids 1999; 15: 1–21
   Web of Science ®Google Scholar
• Rhee YS, Sohn MJ, Woo BH, Thanoo BC, DeLuca PP, Mansour HM. Sustained-release delivery of octreotide from biodegradable polymeric microspheres. AAPS PharmSciTech 2011; 12: 1–9
   PubMedGoogle Scholar
• Rosas JE, Hernández RM, Gascón AR, Igartua M, Guzman F, Patarroyo ME, Pedraz JL. Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66. Vaccine 2001; 19: 4445–51
   PubMed Web of Science ®Google Scholar
• Sánchez A, Tobío M, González L, Fabra A, Alonso MJ. Biodegradable micro-and nanoparticles as long-term delivery vehicles for interferon-alpha. Eur J Pharm Sci 2003; 18: 221–9
   PubMed Web of Science ®Google Scholar
• Schwach G, Oudry N, Delhomme S, Luck M, Lindner H, Gurny R. Biodegradable microparticles for sustained release of a new GnRH antagonist-part I: Screening commercial PLGA and formulation technologies. Eur J Pharm Biopharm 2003; 56: 327–36
   PubMed Web of Science ®Google Scholar
• Shi Y, Li L. Current advances in sustained-release systems for parenteral drug delivery. Expert Opin Drug Deliv 2005; 2: 1039–58
   PubMedGoogle Scholar
• Shi P, Zuo Y, Zou Q, Shen J, Zhang L, Li Y, Morsi YS. Improved properties of incorporated chitosan film with ethyl cellulose microspheres for controlled release. Int J Pharm 2009; 375: 67–74
   PubMed Web of Science ®Google Scholar
• Singh M, O'Hagan D. Advances in vaccine adjuvants. Nat Biotechnol 1999; 17: 1075–81
   PubMed Web of Science ®Google Scholar
• Sinha VR, Trehan A. Biodegradable microspheres for protein delivery. J Control Release 2003; 90: 261–80
   PubMed Web of Science ®Google Scholar
• Sinha VR, Trehan A. Biodegradable microspheres for parenteral delivery. Crit Rev Ther Drug Carrier Syst 2005; 22: 535–602
   PubMed Web of Science ®Google Scholar
• Tamber H, Johansen P, Merkle HP, Gander B. Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv Drug Deliv Rev 2005; 57: 357–76
   PubMed Web of Science ®Google Scholar
• Thompson WW, Anderson DB, Heiman ML. Biodegradable microspheres as a delivery system for rismorelin porcine, a porcine-growth-hormone-releasing-hormone. J Control Release 1997; 43: 9–22
   Google Scholar
• Tobío M, Nolley J, Guo Y, McIver J, Alonso MJ. A novel system based on a poloxamer/PLGA blend as a tetanus toxoid delivery vehicle. Pharm Res 1999; 16: 682–8
   PubMed Web of Science ®Google Scholar
• Tom JW, Debenedetti PG. Particle formation with supercritical fluids: A review. J Aero Sci 1991; 22: 555–84
   Web of Science ®Google Scholar
• Vehring R. Pharmaceutical particle engineering via spray drying. Pharm res 2008; 25: 999–1022
   PubMed Web of Science ®Google Scholar
• Vlugt-Wensink KDF, De Vrueh R, Gresnigt MG, Hoogerbrugge CM, van Buul-Offers SC, de Leede LGJ, Sterkman LGW, Crommelin DJA, Hennink WE, Verrijk R. Preclinical and clinical in vitro in vivo correlation of an hGH dextran microsphere formulation. Pharm Res 2007; 24: 2239–48
   PubMed Web of Science ®Google Scholar
• Wagner JG, Nelson E. Percent absorbed time plots derived from blood level and/or urinary excretion data. J Pharm Sci 1963; 52: 610–11
   PubMed Web of Science ®Google Scholar
• Wang J, Chua KM, Wang CH. Stabilization and encapsulation of human immunoglobulin G into biodegradable microspheres. J Colloid Interface Sci 2004; 271: 92–101
   PubMed Web of Science ®Google Scholar
• Woo BH, Na KH, Dani BA, Jiang G, Thanoo BC, DeLuca PP. In vitro characterization and in vivo testosterone suppression of 6-month release poly(D, L-lactide) leuprolide microspheres. Pharm Res 2002; 19: 546–50
   PubMed Web of Science ®Google Scholar
• Yoo JY, Kim JM, Seo KS, Jeong YK, Lee HB, Khang G. Characterization of degradation behavior for PLGA in various pH condition by simple liquid chromatography method. Biomed Mater Eng 2005; 15: 279
   PubMed Web of Science ®Google Scholar
• Yuan W, Wu F, Guo M, Jin T. Development of protein delivery microsphere system by a novel S/O/O/W multi-emulsion. Eur J Pharm Sci 2009; 36: 212–18
   PubMed Web of Science ®Google Scholar
• Zbikowska HM, Nowak P, Wachowicz B. Protein modification caused by a high dose of gamma irradiation in cryo-sterilized plasma: Protective effects of ascorbate. Free Radic Biol Med 2006; 40: 536–42
   PubMed Web of Science ®Google Scholar
• Zeng J, Yang L, Liang Q, Zhang X, Guan H, Xu X, Chen X, Jing X. Influence of the drug compatibility with polymer solution on the release kinetics of electrospun fiber formulation. J Control Release 2005; 105: 43–51
   PubMed Web of Science ®Google Scholar
• Zolnik BS, Burgess DJ. Effect of acidic pH on PLGA microsphere degradation and release. J Control Release 2007; 122: 338–44
   PubMed Web of Science ®Google Scholar
• Zolnik BS, Burgess DJ. Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres. J Control Release 2008; 127: 137–45
   PubMed Web of Science ®Google Scholar
• Zolnik BS, Leary PE, Burgess DJ. Elevated temperature accelerated release testing of PLGA microspheres. J Control Release 2006; 112: 293–300
   PubMed Web of Science ®Google Scholar